Contact:
Corporate Vice President, Communications & Investor Relations
T: +1 609 524 0065
E: mmp@genmab.com
For Investor Relations:
Senior Director, Investor Relations
T: +45 3377 9558
E: acn@genmab.com
(C) 2020 Electronic News Publishing, source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2,037 DKK | -0.88% | +1.18% | -4.87% |
21/05 | Genmab A/S completed the acquisition of ProfoundBio, Inc. | CI |
15/05 | Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation' | MT |
Contact:
Corporate Vice President, Communications & Investor Relations
T: +1 609 524 0065
E: mmp@genmab.com
For Investor Relations:
Senior Director, Investor Relations
T: +45 3377 9558
E: acn@genmab.com
(C) 2020 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
-4.87% | 19.27B | |
+10.42% | 115B | |
+12.31% | 106B | |
-5.27% | 24.69B | |
-1.19% | 21.97B | |
-11.03% | 17.56B | |
-39.36% | 17.32B | |
+5.89% | 14.03B | |
+33.34% | 12.13B | |
-31.36% | 7.77B |